http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#Head
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#assertion
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#provenance
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#pubinfo
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#assertion
http://purl.obolibrary.org/obo/DOID_289
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_289
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00717
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
http://www.w3.org/2000/01/rdf-schema#label
aygestin norethindrone acetate tablets usp is indicated for the treatment of secondary amenorrhea endometriosis and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology such as submucous fibroids or uterine cancer aygestin norethindrone acetate tablets usp is not intended recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for endometrial protection
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00717
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#provenance
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#pubinfo
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig
http://purl.org/nanopub/x/hasSignature
H0VeovxusxThqRp1pbnlm62fLTBPz1F0L+C6P+HD9eiYgzwG8EY2bPQ/x5OPNtbz4AmVyua86Ss39eEg/3qNZetO4V0AXTA6GmQ1B4PTkbDNWbNZXqz3FQRFzjXbHikOYyhKJ9uWdB0t/gw5UMJ5ppFczSR3iwzCITqB4l8D360=
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
http://purl.org/dc/terms/created
2021-07-03T11:41:55.828+02:00
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs